Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Genetic changes may predict likelihood of relapse in breast cancer patients

Genetic changes may predict likelihood of relapse in breast cancer patients

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Age-related estrogen increase may be the culprit behind inguinal hernias in men

Age-related estrogen increase may be the culprit behind inguinal hernias in men

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Study finds combination therapy to be safe, effective for treatment of male infertility

Study finds combination therapy to be safe, effective for treatment of male infertility

QMUL professor receives Cancer Research UK Lifetime Achievement Award

QMUL professor receives Cancer Research UK Lifetime Achievement Award

Astex celebrates as breast cancer drug gets European marketing approval

Astex celebrates as breast cancer drug gets European marketing approval

Aspirin used in “baby” doses may prevent breast cancer, study suggests

Aspirin used in “baby” doses may prevent breast cancer, study suggests

Researchers find link between hormones and inguinal hernias in older men

Researchers find link between hormones and inguinal hernias in older men

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Pretreatment smoking linked to poor prognosis in AI-treated patients

Pretreatment smoking linked to poor prognosis in AI-treated patients

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Estrogen-inhibiting drug may suppress dangerous brain seizures

Estrogen-inhibiting drug may suppress dangerous brain seizures

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium